ANI Pharmaceuticals Canada Inc., a subsidiary of ANI Pharmaceuticals, has entered into an agreement to sell its former manufacturing facility in Oakville, Ontario for $19.2 million CAD ($14.2 million USD). The transaction is subject to due diligence and customary closing conditions.